Bio-Rad Laboratories, Inc. (BIO) Insider Trading Activity

NYSE$378.245+3.33 (0.89%)
Market Cap
$10.02B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
447 of 849
Rank in Industry
57 of 107

BIO Insider Trading Activity

BIO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$349,886
2
100

Related Transactions

ENGELHARDT EVA ANETTEEVP, President, CDG
0
$0
1
$135,597
$-135,597
BARRY JAMESEVP, President, LSG
0
$0
1
$214,289
$-214,289

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for …

Insider Activity of Bio-Rad Laboratories, Inc.

Over the last 12 months, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $349,886 worth of Bio-Rad Laboratories, Inc. stock.

On average, over the past 5 years, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $2.06M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500 shares for transaction amount of $109,792 was made by HINCKLEY GREGORY K (director) on 2017‑05‑26.

List of Insider Buy and Sell Transactions, Bio-Rad Laboratories, Inc.

2026-05-11SaleENGELHARDT EVA ANETTEEVP, President, CDG
550
0.0021%
$246.54
$135,597
+44.62%
2025-11-06SaleBARRY JAMESEVP, President, LSG
699.87
0.0025%
$306.18
$214,289
-0.76%
2023-12-12SaleWRIGHT DARAEVP, President, CDG
1,200
0.0042%
$299.16
$358,992
+10.06%
2023-11-28SaleCrowley MichaelEVP, GBL Commercial Operations
642
0.0022%
$305.10
$195,874
+5.43%
2023-08-30SaleERNST TIMOTHY SEVP, General Counsel & Sec
2,350
0.0081%
$395.60
$929,667
-20.36%
2023-08-23SaleERNST TIMOTHY SEVP, General Counsel & Sec
300
0.001%
$384.69
$115,407
-18.08%
2023-06-15SaleCrowley MichaelEVP, GBL Commercial Operations
500
0.0017%
$379.39
$189,695
-13.91%
2023-06-06SaleRAMALINGAM AJITSVP, Chief Accounting Officer
198.35
0.0007%
$368.30
$73,053
-11.27%
2023-03-08SaleERNST TIMOTHY SEVP, General Counsel & Sec
1,746
0.006%
$486.43
$849,300
-24.16%
2022-11-10SaleRAMALINGAM AJITSVP, Chief Accounting Officer
379.38
0.0013%
$421.87
$160,051
-6.40%
2022-08-05SaleRAMALINGAM AJITSVP, Chief Accounting Officer
518
0.0017%
$537.00
$278,166
-21.19%
2021-11-12SaleTUMOLO ANNETTEExecutive Vice President
4,800
0.016%
$750.05
$3.6M
-29.26%
2021-11-11SaleTUMOLO ANNETTEExecutive Vice President
1,546
0.0052%
$749.00
$1.16M
-28.86%
2021-09-03SaleDaskal IlanEVP, Chief Financial Officer
270
0.0009%
$820.06
$221,416
-28.93%
2021-09-02SaleDaskal IlanEVP, Chief Financial Officer
540
0.0018%
$828.00
$447,121
-29.43%
2021-09-01SaleLast Andrew J.EVP, Chief Operating Officer
2,000
0.0067%
$813.10
$1.63M
-28.42%
2021-08-26SaleTUMOLO ANNETTEExecutive Vice President
600
0.002%
$792.58
$475,548
-26.32%
2021-08-09SaleCrowley MichaelEVP, GBL Commercial Operations
3,000
0.01%
$754.93
$2.26M
-19.26%
2021-08-04SaleERNST TIMOTHY SEVP, General Counsel & Sec
327
0.0011%
$760.26
$248,605
-19.02%
2021-08-04SaleDaskal IlanEVP, Chief Financial Officer
2,300
0.0076%
$751.84
$1.73M
-19.02%
Total: 222
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
SCHWARTZ ALICE Ndirector, 10 percent owner
1806651
6.7568%
$677.33M12
<0.0001%
SCHWARTZ DAVIDChairman of the Board
8753
0.0327%
$3.28M10
<0.0001%
HUTTON RONALD WVice President and Treasurer
4140
0.0155%
$1.55M117
<0.0001%
HINCKLEY GREGORY Kdirector
500
0.0019%
$187,455.0010
+11%
STARK JAMES RVP, Corporate Controller
0
0%
$0127
<0.0001%
*Gray background shows insiders who have made transactions during last year

BIO Institutional Investors: Active Positions

Increased Positions167+33.81%1M+7.43%
Decreased Positions204-41.3%2M-8.1%
New Positions58New425,847New
Sold Out Positions55Sold Out365,145Sold Out
Total Postitions457-7.49%19M-0.67%

BIO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
First Eagle Investment Management, Llc$769,378.0011.46%2.52M+3,006+0.12%2025-09-30
Vanguard Group Inc$547,513.008.15%1.79M-53,006-2.87%2025-09-30
Blackrock, Inc.$517,692.007.71%1.7M-66,810-3.79%2025-09-30
Dimensional Fund Advisors Lp$324,483.004.83%1.06M+63,370+6.34%2025-09-30
Veritas Asset Management Llp$257,660.003.84%844,039-19,102-2.21%2025-09-30
Ariel Investments, Llc$247,110.003.68%809,480-9,144-1.12%2025-09-30
Earnest Partners Llc$185,996.002.77%609,284+3,398+0.56%2025-09-30
State Street Corp$174,492.002.6%571,599-12,767-2.19%2025-09-30
Bank Of America Corp /De/$140,390.002.09%459,887+7,754+1.72%2025-09-30
Capital Research Global Investors$127,711.001.9%418,355+418,355New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.